| Date | Title | |
| 12/17/09 | MediciNova and Avigen Stockholders Approve Merger |  |
| 12/15/09 | MediciNova and Avigen Confirm Stockholder Election Deadline | |
| 12/09/09 | MediciNova and Avigen Announce Stockholder Election Deadline and Update to Estimated Merger Consideration | |
| 08/21/09 | MediciNova and Avigen Enter Into Definitive Agreement for Business Combination | |
| 08/10/09 | Avigen Reports Second Quarter 2009 Financial Results | |
| 06/25/09 | MediciNova and Avigen Confirm Understanding for Key Terms for a Business Combination | |
| 05/20/09 | Avigen Granted AV411 Patent for Neuropathic Pain | |
| 05/11/09 | Avigen Reports First Quarter 2009 Financial Results | |
| 03/31/09 | Avigen's Stockholders Deny BVF's Bid to Remove Board of Directors in Proxy Fight | |
| 03/26/09 | Avigen Board Discontinues Strategic Merger Discussions to Develop a Plan for Liquidation | |
| 03/18/09 | Leading Independent Advisory Service Urges Avigen Stockholders to Reject BVF's Proposal | |
| 03/11/09 | Avigen's Board Urges Stockholders to Reject BVF's Proposal | |
| 02/25/09 | Avigen Announces Positive Data for AV411 in Pain Relief and Drug Addiction | |
| 02/11/09 | Avigen Reports 2008 Financial Results and Updates Progress On Strategic Review | |
| 02/06/09 | Avigen Board Rejects BVF Offer as Inadequate | |
| 01/26/09 | Avigen's Board of Directors to Review BVF Offer and Provide Recommendation | |
| 01/14/09 | Avigen Retains Independent Strategic Advisors | |
| 12/22/08 | Avigen Board and Management Comment On the Company's Strategic Plans | |
| 12/18/08 | Avigen Sells Early Stage Research Program in Hemophilia to Baxter | |
| 12/03/08 | Avigen to Present At RBC Capital Markets Healthcare Conference | |
| 11/03/08 | Avigen Announces Restructuring and Strategic Direction | |
| 10/28/08 | Avigen Reports Third Quarter 2008 Financial Results | |
| 10/21/08 | Avigen Announces AV650 Did Not Meet Efficacy Endpoints in Phase 2b Clinical Trial for Spasticity in Patients With Multiple Sclerosis | |
| 10/15/08 | Avigen Initiates Opioid Withdrawal Trial in Partnership With NIDA, Columbia University and the New York State Psychiatric Institute | |
| 09/18/08 | Avigen Completes Multi-Center AV650 Phase 2b Spasticity Trial in Patients With Multiple Sclerosis | |
| 09/17/08 | Avigen to Present At UBS Global Life Sciences Conference | |
| 09/03/08 | Avigen Hosts Research Day | |
| 07/30/08 | Avigen Reports Second Quarter 2008 Financial Results | |
| 07/23/08 | Avigen's AV650 Patent Strategy Leads to Expanded Development Agreement | |
| 07/22/08 | Avigen, Inc. Announces Second Quarter 2008 Earnings Conference Call | |
| 06/05/08 | Avigen to Present at Needham & Company Biotechnology and Medical Technology Conference | |
| 04/30/08 | Avigen Reports First Quarter 2008 Financial Results and Discusses AV650 Patent Strategy | |
| 04/23/08 | Avigen, Inc. Announces First Quarter 2008 Earnings Conference Call | |
| 03/11/08 | Avigen to Present At Cowen & Company Health Care Conference | |
| 02/07/08 | Avigen to Present At BIO CEO & Investor Conference | |
| 02/06/08 | Avigen Reports 2007 Financial Results and Reviews Clinical Progress | |
| 01/30/08 | Avigen, Inc. Announces Year-End 2007 Earnings Conference Call | |
| 12/05/07 | Avigen to Present At Upcoming Healthcare Conferences | |
| 11/08/07 | Avigen to Present At 2007 Credit Suisse Phoenix Health Care Conference | |
| 11/04/07 | Avigen Presents At the 37th Annual Meeting of the Society for Neuroscience | |
| 11/03/07 | Avigen's AV411 Shows Promising Initial Results for Neuropathic Pain | |
| 10/30/07 | Avigen to Present At Upcoming Healthcare Conferences | |
| 10/24/07 | Avigen Reports Third Quarter 2007 Financial Results | |
| 10/17/07 | Avigen, Inc. Announces Third Quarter 2007 Earnings Conference Call | |
| 10/03/07 | Avigen to Present At 2007 BIO Investor Forum | |
| 09/18/07 | Avigen to Present At UBS Global Life Sciences Conference | |
| 09/05/07 | Avigen Initiates European Multi-Center AV650 Phase II Spasticity Trial in Patients with Multiple Sclerosis | |
| 08/13/07 | Avigen Initiates U.S. Clinical Development for AV411 | |
| 07/25/07 | Avigen Reports Second Quarter 2007 Financial Results | |
| 07/18/07 | Avigen, Inc. Announces Second Quarter 2007 Earnings Conference Call | |
| 06/26/07 | Expert Opinion Highlights Avigen's AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal | |
| 06/07/07 | Avigen to Present At Needham and Company Biotechnology Conference | |
| 05/01/07 | Avigen to Present at BIO 2007 International Convention | |
| 04/26/07 | Avigen Announces Pricing of Common Stock Offering | |
| 04/24/07 | Avigen Reports First Quarter 2007 Financial Results | |
| 04/19/07 | Avigen, Inc. Announces First Quarter 2007 Earnings Conference Call | |
| 04/04/07 | Avigen to Present At CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference | |
| 03/14/07 | Avigen Receives Approval to Initiate AV650 Phase II Clinical Development | |
| 03/08/07 | Avigen to Present at Cowen and Company Annual Health Care Conference | |
| 03/02/07 | Avigen to Present at Banff 2007: Pharmacology and Therapeutics Conference | |
| 02/27/07 | Avigen to Present At Oppenheimer Pain Management Investor Conference | |
| 02/26/07 | Avigen's AV411 Highlighted in Special Issue of Neuron Glia Biology | |
| 02/07/07 | Avigen Reports 2006 Financial Results and Reviews Clinical Progress | |
| 02/06/07 | Avigen Expands Board of Directors | |
| 02/06/07 | Avigen Completes Safety, Tolerability and Pharmacokinetic Trial For AV411, a Potential First-in-Class Oral Treatment For Neuropathic Pain | |
| 01/31/07 | Avigen, Inc. Announces Fourth Quarter/Year-End 2006 Earnings Conference Call | |
| 01/23/07 | Avigen Speaker Series 2007 | |
| 12/07/06 | Avigen to Present At RBC Capital Markets Healthcare Conference | |
| 12/06/06 | Avigen Completes Phase I Trial for AV650, an Oral Treatment for Neuromuscular Spasm and Spasticity | |
| 11/01/06 | Avigen to Present At Upcoming Healthcare Conferences | |
| 10/25/06 | Avigen Reports Third Quarter 2006 Financial Results | |
| 10/23/06 | Avigen, Inc. Announces Third Quarter 2006 Earnings Conference Call | |
| 10/17/06 | Avigen to Present at BIO InvestorForum 2006 Conference | |
| 09/26/06 | Avigen to Present at UBS Global Life Sciences Conference | |
| 09/12/06 | Avigen to Present "FRONTIERS OF UNMET MEDICAL NEED," a Research Day Showcasing Presentations by Distinguished Educators and Clinicians | |
| 09/05/06 | Avigen to Present at Think Equity Partners Growth Conference | |
| 07/27/06 | Avigen Reports Second Quarter 2006 Financial Results | |
| 07/20/06 | Avigen, Inc. Announces Second Quarter 2006 Earnings Conference Call | |
| 06/22/06 | Avigen Initiates AV650 Clinical Development | |
| 06/12/06 | Avigen Announces Approval for AV411 Phase IIa Trial | |
| 06/08/06 | Avigen to Present at Pacific Growth Equities & Needham Conferences | |
| 05/24/06 | Avigen Announces Presentation of Data at Hemophilia 2006 World Congress | |
| 05/15/06 | Avigen Closes $21.2 Million Private Placement of Common Stock | |
| 05/11/06 | Avigen to Raise Approximately $21.2 Million in Private Placement of Common Stock | |
| 04/27/06 | Avigen Reports First Quarter 2006 Financial Results | |
| 04/21/06 | Avigen, Inc. Announces First Quarter 2006 Earnings Conference Call | |
| 03/30/06 | Avigen to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference | |
| 03/27/06 | Avigen Announces Management Changes | |
| 03/22/06 | Avigen Elects Richard Wallace to Board of Directors | |
| 02/16/06 | Avigen Reports 2005 Financial Results and Reviews Development Pipeline | |
| 02/10/06 | Avigen Announces Fourth Quarter 2005 Earnings Conference Call | |
| 02/10/06 | Avigen to Present at BIO CEO and Investor Conference | |
